How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey (2021)

First Author: Fuggle N
Attributed to:  Programme 3: Early development and risk of adult musculoskeletal disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00198-020-05793-3

PubMed Identifier: 33558957

Publication URI: http://europepmc.org/abstract/MED/33558957

Type: Journal Article/Review

Parent Publication: Osteoporosis International

Issue: 4

ISSN: 0937-941X